140 related articles for article (PubMed ID: 19233506)
1. Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells.
Amatori S; Papalini F; Lazzarini R; Donati B; Bagaloni I; Rippo MR; Procopio A; Pelicci PG; Catalano A; Fanelli M
Lung Cancer; 2009 Nov; 66(2):184-90. PubMed ID: 19233506
[TBL] [Abstract][Full Text] [Related]
2. Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma.
Amatori S; Bagaloni I; Viti D; Fanelli M
Lung Cancer; 2011 Jan; 71(1):113-5. PubMed ID: 21095037
[TBL] [Abstract][Full Text] [Related]
3. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
4. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer.
McCabe MT; Low JA; Daignault S; Imperiale MJ; Wojno KJ; Day ML
Cancer Res; 2006 Jan; 66(1):385-92. PubMed ID: 16397253
[TBL] [Abstract][Full Text] [Related]
6. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
7. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of DNA methyltransferase-mediated gene silencing, anchorage-independent growth, and migration of colon cancer cells by interleukin-6.
Foran E; Garrity-Park MM; Mureau C; Newell J; Smyrk TC; Limburg PJ; Egan LJ
Mol Cancer Res; 2010 Apr; 8(4):471-81. PubMed ID: 20354000
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
Schrump DS; Fischette MR; Nguyen DM; Zhao M; Li X; Kunst TF; Hancox A; Hong JA; Chen GA; Pishchik V; Figg WD; Murgo AJ; Steinberg SM
Clin Cancer Res; 2006 Oct; 12(19):5777-85. PubMed ID: 17020984
[TBL] [Abstract][Full Text] [Related]
10. Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway.
Lavelle D; DeSimone J; Hankewych M; Kousnetzova T; Chen YH
Leuk Res; 2003 Nov; 27(11):999-1007. PubMed ID: 12859993
[TBL] [Abstract][Full Text] [Related]
11. 5-Aza-2'-deoxycytidine induces cytotoxicity in BGC-823 cells via DNA methyltransferase 1 and 3a independent of p53 status.
Liu J; Zhang Y; Xie YS; Wang FL; Zhang LJ; Deng T; Luo HS
Oncol Rep; 2012 Aug; 28(2):545-52. PubMed ID: 22664909
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
13. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
[TBL] [Abstract][Full Text] [Related]
15. p21Waf1/Cip1 plays a critical role in modulating senescence through changes of DNA methylation.
Zheng QH; Ma LW; Zhu WG; Zhang ZY; Tong TJ
J Cell Biochem; 2006 Aug; 98(5):1230-48. PubMed ID: 16514663
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.
Belinsky SA; Klinge DM; Stidley CA; Issa JP; Herman JG; March TH; Baylin SB
Cancer Res; 2003 Nov; 63(21):7089-93. PubMed ID: 14612500
[TBL] [Abstract][Full Text] [Related]
17. Decitabine--bedside to bench.
Oki Y; Aoki E; Issa JP
Crit Rev Oncol Hematol; 2007 Feb; 61(2):140-52. PubMed ID: 17023173
[TBL] [Abstract][Full Text] [Related]
18. Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.
Mund C; Hackanson B; Stresemann C; Lübbert M; Lyko F
Cancer Res; 2005 Aug; 65(16):7086-90. PubMed ID: 16103056
[TBL] [Abstract][Full Text] [Related]
19. Demethylation of DNA by decitabine in cancer chemotherapy.
Brown R; Plumb JA
Expert Rev Anticancer Ther; 2004 Aug; 4(4):501-10. PubMed ID: 15270655
[TBL] [Abstract][Full Text] [Related]
20. DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8.
Kurita S; Higuchi H; Saito Y; Nakamoto N; Takaishi H; Tada S; Saito H; Gores GJ; Hibi T
Cancer Sci; 2010 Jun; 101(6):1431-9. PubMed ID: 20398055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
